Testing effectiveness (Phase 2)Study completedNCT02784392
What this trial is testing
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
Who this might be right for
Enteral Feeding Intolerance (EFI)
Lyric Pharmaceuticals 120